| Income Statement |
| Total Revenue | 3.04B |
|
| Revenues (USD) | 3.04B |
| Cost of Revenue | 1.13B |
| Gross Profit | 1.91B |
| Operating Expenses | 532.30M |
| Research and Development Expense | 348.20M |
| Selling, General and Administrative Expense | 184.10M |
| Operating Income | 1.38B |
| Income Tax Expense | 291.40M |
| Net Income | 1.21B |
| Net Income Common Stock | 1.21B |
| Net Income Common Stock (USD) | 1.21B |
| Consolidated Income | 1.21B |
| Earnings per Basic Share | 0.96 |
| Earnings per Basic Share (USD) | 0.96 |
| Earnings per Diluted Share | 0.95 |
| Earning Before Interest & Taxes (EBIT) | 1.50B |
| Earning Before Interest & Taxes (USD) | 1.50B |
| Weighted Average Shares | 1.26B |
| Weighted Average Shares Diluted | 1.28B |
| Balance Sheet |
| Cash and Equivalents | 2.29B |
| Cash and Equivalents (USD) | 2.29B |
| Investments | 11.05B |
| Investments Current | 11.05B |
| Trade and Non-Trade Receivables | 2.27B |
| Current Assets | 20.16B |
| Property, Plant & Equipment Net | 312.50M |
| Total Assets | 23.72B |
| Current Liabilities | 6.82B |
| Total Liabilities | 8.92B |
| Accumulated Retained Earnings (Deficit) | 11.68B |
| Accumulated Other Comprehensive Income | -40.50M |
| Shareholders Equity | 14.80B |
| Shareholders Equity (USD) | 14.80B |
| Assets Non-Current | 3.56B |
| Deferred Revenue | 6.87B |
| Goodwill and Intangible Assets | 416.10M |
| Inventory | 2.54B |
| Liabilities Non-Current | 2.10B |
| Trade and Non-Trade Payables | 692.70M |
| Tax Assets | 2.00B |
| Cash Flow |
| Depreciation, Amortization & Accretion | 23.40M |
| Net Cash Flow from Financing | -1.50M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -499.30M |
| Capital Expenditure | -29.70M |
| Issuance (Purchase) of Equity Shares | 3.50M |
| Net Cash Flow from Investing | -1.58B |
| Net Cash Flow - Investment Acquisitions and Disposals | -1.51B |
| Net Cash Flow from Operations | 1.08B |
| Effect of Exchange Rate Changes on Cash | -1000.00K |
| Share Based Compensation | 120.40M |